FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program - Webinar By GCP 2011

The webinar deals with FDA perspective for Auditing or Inspecting a study, The Sponsor`s responsibility and monitoring system components, Protocol knowledge, preventing errors, Preparation for an audit or inspection and Measures for quality monitoring.

The event brings together personnel from Pharmaceutical, Biotechnology and CRO industries.